ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
ExcelFemale
HRT in Women
Treating Low Sexual Desire in the Post-Menopausal Woman
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 85220" data-attributes="member: 2624"><p>At the present tine. flibanserin (<strong>Addyi,</strong> Valeant Pharmaceuticals) is the only approved therapy for hypoactive sexual desire disorder in women. However, it is only indicated for use in premenopausal women. </p><p></p><p>According to Dr. Sheryl Kingsberg, hypoactive sexual desire disorder is the most prevalent sexual dysfunction of women of all ages, but the highest rates are among postmenopausal women. Data presented by Kingsberg revealed that flibanserin was more effective than placebo in improving not only the desire domain on the Female Sexual Function Index, as previously reported by results from the Snow Drop Trial, but also improves all domains related to sexual function. </p><p></p><p>"Fibanserin May Be Effective Treatment For Hypoactive Sexual Desire in Post-Menopausal Women," <em>Healio, Endocrine Today, 12 October 2017</em></p><p><em></em></p><p><em><a href="https://www.healio.com/endocrinology/hormone-therapy/news/online/%7B89ed9174-93be-460b-8d50-75e4484f3f89%7D/video-flibanserin-may-be-effective-treatment-for-hypoactive-sexual-desire-disorder-in-postmenopausal-women" target="_blank">https://www.healio.com/endocrinology/hormone-therapy/news/online/{89ed9174-93be-460b-8d50-75e4484f3f89}/video-flibanserin-may-be-effective-treatment-for-hypoactive-sexual-desire-disorder-in-postmenopausal-women</a></em></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 85220, member: 2624"] At the present tine. flibanserin ([B]Addyi,[/B] Valeant Pharmaceuticals) is the only approved therapy for hypoactive sexual desire disorder in women. However, it is only indicated for use in premenopausal women. According to Dr. Sheryl Kingsberg, hypoactive sexual desire disorder is the most prevalent sexual dysfunction of women of all ages, but the highest rates are among postmenopausal women. Data presented by Kingsberg revealed that flibanserin was more effective than placebo in improving not only the desire domain on the Female Sexual Function Index, as previously reported by results from the Snow Drop Trial, but also improves all domains related to sexual function. "Fibanserin May Be Effective Treatment For Hypoactive Sexual Desire in Post-Menopausal Women," [I]Healio, Endocrine Today, 12 October 2017 [URL]https://www.healio.com/endocrinology/hormone-therapy/news/online/%7B89ed9174-93be-460b-8d50-75e4484f3f89%7D/video-flibanserin-may-be-effective-treatment-for-hypoactive-sexual-desire-disorder-in-postmenopausal-women[/URL][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
ExcelFemale
HRT in Women
Treating Low Sexual Desire in the Post-Menopausal Woman
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top